Sunshine Biopharma, Inc.
NASDAQSunshine Biopharma heads into its May 20 earnings event with short sellers retreating sharply and borrow conditions markedly looser than they were six weeks ago. The short interest story is the clearest signal this week — and it tells a de-escalation narrative. Short interest has dropped 25% over the past week alone, and is down 41% from a month ago. It now stands at roughly 1.7%…
SBFM short interest plunges 24.7% in one week to 1.65% of float, lowest level since early April.
Snapshot as of 14 May 2026
Sunshine Biopharma heads into its May 20 earnings event with short sellers retreating sharply and borrow conditions markedly looser than they were six weeks ago. The short interest story is the clearest signal this…
SBFM heads into tomorrow's earnings report as a micro-cap biotech with a sliding stock, a shrinking short book, and a lending market that remains active but far from stressed. Short sellers have been covering steadily.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SBFM — free to start on ORTEX.
Sign up for free →Open SBFM on ORTEX